Evgenia Verrou

Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw

Konstantinos Vahtsevanos, Αthanassios Kyrgidis, Evgenia Verrou et al. · Journal of Clinical Oncology · 2009 · 464 citations

Medicine, Oncology, Cancer Prevention +8

Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single‐centre experience in 303 patients

Kostas Zervas, Evgenia Verrou, Zisis Teleioudis et al. · British Journal of Haematology · 2006 · 296 citations

Medicine, Oral Pathology, Bone Metabolism +12

Bortezomib reduces serum dickkopf‐1 and receptor activator of nuclear factor‐<i>κ</i>B ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma

Evangelos Terpos, Deborah J. Heath, Amin Rahemtulla et al. · British Journal of Haematology · 2006 · 221 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma

Ashraf Badros, Evangelos Terpos, Eirini Katodritou et al. · Journal of Clinical Oncology · 2008 · 144 citations · Full text

Dentistry, Oral Surgery, Dentoalveolar Surgery +10

Treatment with bortezomib‐based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group

Eirini Katodritou, Evangelos Terpos, Charikleia Kelaïdi et al. · American Journal of Hematology · 2013 · 70 citations · Full text

Medicine, Hematology, Pharmacology +11